USANA Health Sciences Inc. (USNA) exhibits 78.3% gross margins and 7.9% return on invested capital within Health Care (Medicinal Chemicals and Botanical Products), balanced against a 2.7x enterprise multiple and 4.8% implied options volatility.
Sustained 78.3% gross profitability converts into 4.0% operating margin and 7.9% ROIC, outpacing sector cost of capital.
ROIC: 7.9% // GM: 78.3%YoY revenue trajectory of +8.3% paired with 3.22% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +8.3% // FCF YLD: 3.22%Altman Z-Score of 3.56 and Piotroski F-Score of 7/9 indicate low near-term refinancing stress.
ALTMAN Z: 3.56 // F-SCORE: 7/9Trading at 24.6x trailing P/E (22.9x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 24.6x // EV/EBITDA: 2.7xOptions market prices a ±5.2% implied move with a 0.85 put/call ratio around $14.34 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Medicinal Chemicals and Botanical Products require continuous execution to defend 1.2% net margins.
NET MARGIN: 1.2% // D/E: 0.45x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for USNA & activate live FRED threshold breach alerts.